Ajanta Pharma Share Price Target 2025 to 2040 Forecast & Fundamentals

Published on: September 24, 2024

Here, we are going to share Ajanta Pharma Share Price Target 2025 to 2040 on the basis of its fundamental and technical analysis.

Ajanta Pharma is an Indian multinational pharmaceutical company known for the development, manufacture, and marketing of branded and generic pharmaceutical formulations.

If you are thinking for making an investment decision in Ajanta Pharma Ltd then the information shared in this article will be very beneficial for you, as we are going to share Ajanta Pharma Company Overview, Quarterly Results, Profits and Loss, Competitors, Bull and Bears cases along with Ajanta Pharma Share Price Target for 2025 to 2040.

Ajanta Pharma Company Overview

Founded: 1973
Founder: Mannalal Agrawal, Madhu Sudan Agrawal and Purshottam Agrawal
Headquarters: Mumbai, Maharashtra
No of Employees: Approx. 8,000
Listed in: NSE and BSE
Industry: Pharmaceuticals & Drugs
Key Areas of Focus: Manufacturing and marketing of Medicines related to ophthalmology, dermatology, cardiology, and pain management.
Global Presence: The company has a strong presence in more than 30 countries including United States, Asia, Africa and Latin America.
Financial Performance: The company has shown consistent growth in revenue and profitability as well.

Ajanta Pharma Share Key Information

Company Name	Ajanta Pharma Ltd
Headquarters	Mumbai, Maharashtra
Sectors	Pharmaceuticals & Drugs
Market Cap	₹ 40,262.29 Cr.
No. of Shares	12.49Cr.
Book Value	₹291.70
Dividend Yield	1.65%
ROCE	33.15%
ROE	24.26%
Face Value	₹2
Sales Growth	16.41%
Profit Growth	44.48%

Ajanta Pharma Business Sector

Ajanta Pharma operates in several key business sectors, focusing on both branded and generic pharmaceutical formulations.

Cardiology: Treating cardiovascular conditions like hypertension and heart disease.
Ophthalmology: Eye care products, including treatments for conditions like glaucoma and conjunctivitis.
Dermatology: Products for skin care, including treatment of acne, fungal infections, and other skin conditions.
Pain Management: Analgesics and anti-inflammatory drugs.
Gastroenterology: Treatments for digestive system disorders.

Ajanta Pharma’s diversified business sectors allow it to maintain a strong market presence across various regions and therapeutic categories, positioning the company for sustainable growth and market expansion.

Board Members

Madhusudan Agrawal – Vice Chairman.
Yogesh M. Agrawal – Managing Director.
Rajesh M. Agrawal – Managing Director.
Ranjit Singh – Managing Director.
B. L. Kheruka – Independent Director.
Anant H. Bhatt – Independent Director.
Dinesh Mehta – Independent Director.
Rama Kirloskar – Independent Director.

Ajanta Pharma Share Quarterly Results

PARTICULARS	Mar 2024	Jun 2024
Net Sales	926.07	1,077.27
Total Expenditure	698.92	761.44
Operating Profit	227.15	315.83
Other Income	33.68	28.37
Interest	1.42	0.72
Depreciation	33.47	32.92
Exceptional Items	0	0
Profit Before Tax	225.94	310.56
Tax	63.25	74.53
Profit After Tax	162.69	236.03
Adjusted EPS (Rs)	12.88	18.83

Also Read

Suven Pharma Share Price Target 2025 to 2040 Forecast & Fundamentals

Ajanta Pharma Company Profits and Losses

PARTICULARS	Mar 2023	Mar 2024
Net Sales	3,411.27	3,971.12
Total Expenditure	2,711.99	2,851.69
Operating Profit	699.28	1,119.43
Other Income	132.75	116.48
Interest	5.23	6.80
Depreciation	126.95	132.16
Exceptional Items	0	0
Profit Before Tax	699.85	1,096.95
Tax	141.13	289.71
Net Profit	558.72	807.24
Adjusted EPS (Rs.)	44.38	64.12

Ajanta Pharma Share Price Target 2025-2040

Year	Initial Target	Year-End Target
2025	₹3402	₹3545
2026	₹3565	₹3735
2027	₹3765	₹3956
2028	₹3965	₹4145
2029	₹4159	₹4395
2030	₹4420	₹4705
2035	₹6125	₹7150
2040	₹9150	₹9950

Also Read

Gland Pharma Share Price Target 2025 to 2040 Forecast & Fundamentals